Atypical haemolytic uraemic syndrome (aHUS) - eculizumab or ravulizumab - recommencement authority application form (PB176)

Use this form to apply to recommence PBS-subsidised treatment with eculizumab or ravulizumab for aHUS.

Page last updated: 1 January 2024.
QC 34216